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Abstract
Background: Lung maturation is a late fetal developmental event in both mice and humans. Because of this, lung
immaturity is a serious problem in premature infants. Disruption of genes for either the glucocorticoid receptor
(Nr3c1) or the NFIB transcription factors results in perinatal lethality due to lung immaturity. In both knockouts, the
phenotype includes excess cell proliferation, failure of saccularization and reduced expression of markers of epithelial
differentiation. This similarity suggests that the two genes may co-regulate a specific set of genes essential for lung
maturation.
Results: We analyzed the roles of these two transcription factors in regulating transcription using ChIP-seq data for
NFIB, and RNA expression data and motif analysis for both. Our new ChIP-seq data for NFIB in lung at E16.5 shows that
NFIB binds to a NFI motif. This motif is over-represented in the promoters of genes that are under-expressed in
Nfib-KO mice at E18.5, suggesting an activator role for NFIB. Using available microarray data from Nr3c1-KOmice, we
further identified 52 genes that are under-expressed in both Nfib and Nr3c1 knockouts, an overlap which is 13.1 times
larger than what would be expected by chance. Finally, we looked for enrichment of 738 recently published
transcription factor motifs in the promoters of these putative target genes and found that the NFIB and glucocorticoid
receptor motifs were among the most enriched, suggesting that a subset of these genes may be directly activated by
Nfib and Nr3c1.
Conclusions: Our data provide the first evidence for Nfib and Nr3c1 co-regulating genes related to lung maturation.
They also establish that the in vivo DNA-binding specificity of NFIB is the same as previously seen in vitro, and highly
similar to that of the other NFI-family members NFIA, NFIC and NFIX.
Keywords: Lung development, Nr3c1, Glucocorticoid receptor, Nfib, Regulation of transcription, ChIP-seq analysis,
Expression analysis, Motif analysis, Transcription factor
Background
Lung development is a complex developmental process
initiated by budding of the lungs from the gut endoder-
mal tube, multiple rounds of expansion and branching
morphogenesis, and final maturation of the epithelial and
endothelial components that comprise the airways, pul-
monary circulation, and gas exchange surface [1,2]. It is
the final maturation of the lung epithelial cells that is fre-
quently interrupted by premature birth, leading to both
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acute and chronic lung disease in premature infants [3,4].
Here we demonstrate apparently related roles of the Nfib
and glucocorticoid receptor (hereafter either Nr3c1 or
GR) genes in lung maturation.
Previous studies showed that loss of Nfib resulted in
perinatal lethality due to lung immaturity [5]. The lungs
of late fetal mice lacking Nfib showed reduced expres-
sion of Type I and Type II epithelial markers along with
morphological immaturity exemplified by a failure of the
formation of saccules, the precursor to the alveolar air
exchange region. In addition, excess proliferation of both
mesenchymal and epithelial cells is seen inNfib null lungs.
Surprisingly, while the phenotype is clearly related to the
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failure of epithelial cell maturation, loss ofNfib only in the
mesenchymal cells of the lung yields a very similar phe-
notype [6], indicating that mesenchymal cells regulate late
epithelial maturation through as yet unknown inductive
mechanisms [7].
Prenatal administration of glucocorticoids has been
shown to stimulate lung maturation in both mice and
premature infants [8-10]. Conversely, deletion of Nr3c1,
the gene encoding the glucocorticoid receptor, results in
a phenotype remarkably similar to that of loss of Nfib,
including excess cell proliferation, failure of saccular-
ization and reduced expression of markers of epithelial
differentiation [10]. As with Nfib, loss of Nr3c1 only in
the mesenchyme recapitulates much of this phenotype
[11]. The similarity in phenotype seen with the loss of
either Nfib or Nr3c1, together with the shared cell-type
expression requirement suggests that these two genes may
co-regulate a specific set of genes essential for lung mat-
uration. We therefore examined the lung genes regulated
by Nfib and Nr3c1 and the specific binding targets of
NFIB to determine how these genes may cooperate in the
regulation of lung maturation.
Results
ChIP-seq shows that NFIB binds to the known NFI motif in
mouse fetal lung
We conducted a ChIP-seq analysis of NFIB in wild
type mouse fetal lung at E16.5 and identified 759 peaks
from an initial set of 8,717,818 unpaired reads (see
Methods). The distribution of the distances between these
peaks and the closest TSS shows a strong enrichment
within 1 kbp both upstream and downstream of the TSSs
compared to a random control (Figure 1). Peaks are par-
ticularly enriched at about 100bp upstream of the nearest
known TSS, showing that NFIB frequently binds the prox-
imal promoter. There is also considerable enrichment of
peaks downstream of the nearest known TSS for several
hundred base-pairs. This could represent either binding in
the 5’UTR of the known gene or binding in the promoter
of an unannotated alternative transcript.
We applied the MEME algorithm [12] to repeat-masked
[13], 100bp genomic regions centered on each of the 759
NFIB ChIP-seq peaks. The most statistically significant
motif found by MEME matches the known NFIB palin-
dromic consensus sequence TGGCnnnnnGCCA. More
importantly, the motif found by MEME is extremely sim-
ilar to the in vitro NFIB motif obtained by Jolma et al.
[14] using SELEX technology (Figure 2). This observation
confirms that NFIB has similar DNA-binding specificity
in mouse fetal lung cells as in a cell-free in vitro system.
The palindromic binding motif found by MEME further
strongly suggests that NFIB binds mainly as a dimer in
these cells. Finally, the strong similarity between the in
vivo and in vitro motifs for NFIB in Figure 2 show that
Figure 1 Distribution of NFIB ChIP-seq peaks relative to closest
TSS. The black curve represents the distribution of the distances
between the 759 NFIB ChIP-seq peaks and the closest TSS. Negative
distances correspond to upstream peaks and positive distances to
downstream peaks. The red curve shows the distances when the
peaks are randomly and uniformly repositioned on their
chromosomes. Density is estimated using a Gaussian kernel with
bandwidth h = 0.4.
the ChIP-seq experiment and downstream data analysis
succeeded.
To further assess the quality of our ChIP-seq data, we
considered the fraction of predicted ChIP-seq peaks that
contain a match to the discovered NFIB motif at different
motif score thresholds, as computed by the FIMO scan-
ning algorithm [15]. At a motif score p-value threshold
of 10−5, the NFIB motif is present in 10.1% of the ChIP-
seq peaks but in only 1.7% of the randomized control
sequences (Figure 3). This represents a six-fold enrich-
ment (77/13 = 5.92), which exceeds the ENCODE guide-
lines requiring at least 10% of the peaks to have a four-fold
enrichment for the ChIPed TF’s binding motif [16].
Correlation of NFIB binding and expression of nearby genes
We studied the mechanism of transcriptional regulation
by NFIB in fetal lung cells using our NFIB ChIP-seq data
from E16.5 fetal lung cells and previously published gene
expression data from E18.5 fetal lung cells in WT and
Nfib-knockout mice [6].
We first sought for dysregulated genes in the Nfib-KO
using a 2-fold expression change threshold and a maximal
q-value of 0.05 for selection (see Methods).
We identified 631 genes, of which 412 are down-
regulated and 219 are up-regulated. For convenience,
we will refer to the down-regulated genes as “NFIB-
activated”, and to the up-regulated as “NFIB-repressed”.
Of course, we realize that the observed effect could be
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Figure 2 NFIB DNA-binding motifs in mouse fetal lung and in vitro. The motif reported by Jolma et al. [14] using SELEX is shown above the
motif discovered by MEME in mouse fetal lung NFIB ChIP-seq peak regions.
due to direct or indirect regulation of the gene in question
(e.g., via NFIB interacting with another TF).
We then counted the numbers of genes with an NFIB
ChIP-seq peak within 1 kbp, 10 kbp or 100 kbp (Table 1).
As can be seen in Table 1, only 0.3% of the NFIB-activated
genes (1 gene) have an NFIB ChIP-seq peak within 1 kbp
of their TSS. This is a lower percentage than for all genes
Figure 3 Enrichment of the NFIB motif in NFIB ChIP-seq peaks.
The black curve shows the fraction of 759 ChIP-seq peaks with at least
one predicted NFIB binding site using different motif score thresholds.
The red curve shows distribution obtained when each ChIP-seq peak
region is shuffled while preserving trinucleotide frequencies.
(1.2%), but the difference is not statistically significant
(p = 0.1, two-tailed Fisher’s exact test).
If we extend the analysis to binding at up to 10 kbp
and 100 kbp from the TSS, neither the NFIB-activated nor
NFIB-repressed genes have a number of NFIB ChIP-seq
peaks that differs significantly from the number expected
by chance (p > 0.05, two-tailed Fisher’s exact test).
The lack of evidence of a clear relationship between
proximal NFIB binding and gene expression in Table 1
may be due to the fact that the expression data is from
a later stage of fetal lung development than the ChIP-
seq data (E18.5 vs. E16.5). It is quite possible that the set
of genes bound by NFIB changes substantially between
E16.5 and E18.5. Another confounding factor is that the
gene expression data comes from embryonic lungs where
Nfib is deleted from E10, but expression is not mea-
sured until E18.5, leaving ample time for compensatory
Table 1 Number of NFIB-activated/repressed genes with
an NFIB ChIP-seq peak near their TSS
≤1 kbp ≤10 kbp ≤100 kbp
Activated (396) 0.3% (1) 1.3% (5) 10.6% (42)
Repressed (203) 1.0% (2) 2.0% (4) 8.4% (17)
All (11383) 1.2% (140) 2.2% (255) 11.6% (1324)
The table shows the percentage (number) of NFIB-activated, NFIB-repressed or
all genes that have an NFIB peak within the given distance of their TSS.
Percentages are in terms of the total number of genes in the given class. Note
that we consider only genes for which we have both distance and expression
data, so the numbers of activated/repressed genes presented in this table are
slightly lower than the total number of NFIB-activated genes (412) and
NFIB-repressed genes (219).
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changes in gene expression. In fact among the 631 genes
identified as activated or repressed at day E18.5 in the
Nfib-KO mouse, 28 are annotated as having “sequence-
specific DNA binding transcription factor activity” in
the Gene Ontology (GO) database [17]. The changes in
expression of these TFs will affect the expression of many
genes, so many of the observed dysregulated genes may
be indirect rather than direct targets of Nfib. Another
possibility is that the majority of regulation by NFIB is
via long-distance chromatin looping [18], but we con-
sider this unlikely given the clear enrichment of NFIB
binding events we observe in proximal promoter regions
(Figure 1).
Promoters of genes activated by NFIB are enriched in NFIB
motifs, but repressed ones are not
In the absence of ChIP-seq data in E18.5 mouse fetal
lung, we turned to a motif-based analysis of the relation-
ship between NFIB binding and gene expression. First,
we tested for over-representation of putative NFIB bind-
ing sites (predicted using our new NFIB motif ) in the
promoters of NFIB-activated and NFIB-repressed genes
(see Methods). We found a significant enrichment in
the NFIB-activated genes (pact < 0.0013), but not in
the NFIB-repressed (prep > 0.3). This suggest that
many genes are activated by NFIB through direct inter-
action, but that repression generally results from indirect
regulation.
As a control and to get a broader picture, we then
calculated pact and prep and our motif association score
(MAS, see Methods) for each of the 738 SELEX-derived
motifs reported by Jolma et al. [14], which cover the DNA-
binding specificity of most transcription factor families in
mammals. We found that the three motifs with the largest
MAS are the three NFI-family motifs in the Jolma et al.
[14] compendium (Figure 4 and Table 2). These motifs
have large positiveMAS scores, which indicates that their
presence in the promoter of a gene is highly correlated
with it having reduced expression in the Nfib-KO mouse
at E18.5. This suggests that NFIB acts as a direct activator
of transcription for many genes in our NFIB-activated set,
in mouse fetal lung at E18.5. The complete MAS results
are given in Additional file 1.
As an additional control, we repeated the complete
MAS analysis after replacing mouse promoter sequences
by their ortholog from rat or human. For both species,
NFI motifs were among the most strongly enriched within
the set of NFIB-activated genes. In human, NFIX ranked
second (pact < 10−4), andNFIB ranked fourteenth (pact <
10−3). In rat, NFIX ranked third (pact < 10−3) and NFIB
ranked tenth (pact < 10−3). Overall, this strongly support
the hypothesis that NFIB activates its targets during lung
maturation through direct interactions near the promoter
regions.
Figure 4Motif Association Score distribution forNfib targets. The
histogram shows the distribution of the MAS for the 739 motifs in the
compendium (our ChIP-seq motif inferred with MEME (Nfib_MEME)
plus 738 mouse and human TF motifs determined by SELEX [14]).
Table 2 Association of TFmotifs with Nfib targets
Motif Gene FC pact prep MAS
NFIA_full Nfia 2.27 < 10−5 0.31 5.50
NFIB_full Nfib *2.75 < 10−5 0.27 5.12
NFIX_full Nfix - < 10−4 0.26 4.67
Meis3_DBD_2 Meis3 NA < 10−4 0.44 4.13
MEIS3_DBD_2 Meis3 NA < 10−4 0.44 4.03
Meis2_DBD_2 Meis2 1.57 0.0001 0.53 3.98
SNAI2_DBD Snai2 1.72 0.0002 0.86 3.78
Rxra_DBD Rxra - 0.0004 0.54 3.49
EBF1_full Ebf1 - 0.0004 0.46 3.49
Rxrb_DBD Rxrb NA 0.0004 0.69 3.49
NR2F6_DBD_2 Nr2f6 - 0.0004 0.75 3.46
RXRA_DBD Rxra - 0.0006 0.62 3.22
NR2F1_DBD Nr2f1 1.83 0.0007 0.74 3.18
RXRB_DBD Rxrb NA 0.0007 0.41 3.16
Pknox2_DBD Pknox2 - 0.0009 0.41 3.05
TFAP4_full Tfap4 NA 0.0010 0.24 3.02
PKNOX2_DBD Pknox2 - 0.0010 0.60 3.00
RXRG_DBD Rxrg NA 0.0011 0.49 2.96
NR2C2_DBD Nr2c2 - 0.0012 0.65 2.93
Nfib_MEME Nfib *2.75 0.0012 0.34 2.92
The table shows the TF motif name (motif), associated gene name (gene),
expression fold-change (FC) of the gene, the (unadjusted) motif enrichment
p-value in the activated set of genes (pact ), the (unadjusted) motif enrichment
p-value in the repressed set of genes (prep), and the motif association score
(MAS). Rank is based on the magnitude of the MAS, “NA” indicates that no
expression data is available for the TF gene and “-” in the FC column indicates
that expression change is not significant (p-value> 0.05). Motif names all in
uppercase are derived from human TFs, others are frommouse TFs. *Although
Nfib expression increases in the Nfib-KO, no functional protein is produced.
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The presence of our novel, ChIP-derived NFIB motif
in gene promoters shows less significant correlation with
gene expression than the SELEX-based motifs for NFIA,
NFIB and NFIX (Table 2). The new motif (NFIB_MEME)
ranks twentieth according to MAS, despite being highly
similar to the SELEX-based NFIB motif (Figure 2), from
which it differs primarily in the preference for an ‘A’ in the
right-most position. This may indicate that the new, ChIP-
based motif is slightly less accurate than the SELEX-based
motif, which, if true, could be due to numerous reasons.
The accuracy of motifs derived from ChIP-seq exper-
iments depends strongly on the number of sequences
without the motif presented to the motif discovery algo-
rithm. Such sequences can be due to imperfect antibody
specificity or to indirect DNA-binding by the antibody via
a protein complex or via chromatin loops bound jointly
by the antibody and another DNA-binding protein [19].
None of these issues are present in SELEX experiments,
although they suffer from their own limitations. There
is no guarantee that the DNA-binding specificity of the
protein or DNA-binding domain assayed by SELEX is
the same under the in vitro SELEX conditions as it is
in in vivo. At any rate, our expression correlation results
suggest that the existing SELEX-based NFI-family motifs
are at least as accurate as our ChIP-derived motif for
NFIB.
Although our new NFIB motif ranks twentieth among
the 739 motifs in the combined motif database, there are
effectively only three distinct motifs with higher MAS
scores (Figure 5). This is because the compendium con-
tains motifs for both mouse and human TFs (e.g., Meis3
and MEIS3) and it contains multiple members of tran-
scription factor families. Paralogous and orthologous TFs
tend to have highly similar DNA-binding affinities, as
shown by the highly similar motif logos at the leaves of the
motif tree in Figure 5.
Other TFs may contribute to the Nfib-KO phenotype
For each motif in Table 2 we have included the expres-
sion fold change of the corresponding gene, if significant
(p-value ≤ 0.05). The increased expression of Nfia in the
Nfib-KO further suggests that there may be some com-
pensatory mechanism at play between the two paralogs.
Since the DNA-binding motif of NFIA is almost identi-
cal to that of NFIB, it is probable that both transcription
factors bind to the same regulatory elements. Such an
apparently compensatory change in one NFI family mem-
ber upon loss of another was noted previously in Nfib-KO
lungs and suggests some type of homeostatic regulation
of total NFI levels [5]. However, these data are not suf-
ficient to indicate whether NFIA acts as an activator or
a repressor, or whether the same genes are regulated by
both NFIA and NFIB.
In addition to the NFI motifs, we note the large positive
MAS of the Meis, SNAI2 and NR2F1 motifs, indicat-
ing that they are enriched in the NFIB-activated gene
set (i.e. in genes that are under-expressed in the Nfib-
KO). Because Snai2, Meis2 and Nr2f1 are over-expressed
in the Nfib-KO, it is possible that some genes in our
NFIB-activated set are repressed by these genes instead
of being directly activated by NFIB. Repressor activity
has been documented for each of these three factors
[22-24]. For example Snai2, which represses transcrip-
tion via the recruitment of histone deacetylases to target
gene promoters [25], is known for its antiapoptotic activ-
ity and plays a role in epithelial-mesenchymal transi-
tion. While neither epithelial-mesenchymal transition nor
altered apoptosis seem implicated in the phenotype of
Nfib-/- lungs [6], other epigenetic changes mediated by
Snai2 affecting cell proliferation and cell differentiation
are clearly possible and will be investigated. Finally, we
note the enrichment of the EBF1 motif, which regu-
lates cell differentiation [26]. However, according to the
microarray data, the Ebf1 gene is not significantly dysreg-
ulated in the Nfib-KO.
The apparently paradoxical increased expression ofNfib
in the Nfib-KO lungs (Table 2) is explained by the fact
that only exon 2 (containing the DNA-binding domain
and dimerization domain) is actually knocked out. The
microarray is detecting an increase in a transcript that
is missing exon 2, and thus cannot lead to a func-
tional NFIB protein. One explanation for this increased
expression from the Nfib promoter in the absence of
production of a functional Nfib transcript is that NFIB
normally represses its own production, either directly
or indirectly (Table 3). A second possibility is that the
shorter, disrupted transcript is less subject to post-
transcriptional degradation that the complete transcript,
leading to higher measured expression in the Nfib-KO
lungs.
Nfib and Nr3c1 regulate an overlapping set of genes
Nfib-knockout mice show a phenotype very similar to that
seen in glucocorticoid receptor (Nr3c1) knockoutmice. To
ask whether this may be due to a common set of dysreg-
ulated genes, we compared our Nfib-KO microarray data
with available microarray data for Nr3c1-KO in fetal mice
lung at 18.5 [27]. Using the same selection threshold as
for the Nfib-KO dataset (2-fold expression change and q-
value ≤ 0.05), we identified 158 activated genes and 160
repressed genes by GR.
The sets of genes activated or repressed by GR over-
lap significantly with the analogous gene sets for NFIB
(Table 4). The sets of activated genes share 52 genes in
common, which is 13.1 times higher than what would be
expected by chance, while the sets of repressed genes have
22 genes in common, a 9-fold enrichment.






















Figure 5Motifs associated with dysregulated genes in Nfib-KOmouse clustered by motif similarity. The tree shows the top 20 motifs
according to MAS clustered using the Pearson Correlation Coefficient to measure the similarity between pairs of motifs, and the UPGMA
tree-building algorithm to create the tree [20]. The tree was drawn using Phylodendron [21].
As we can see from Figure 6, the direction of the change
in expression is the same for all but one of the genes
activated/repressed in the two knockout experiments
(Figure 6). The one gene whose expression changes in a
different direction is Aspg (log2(FC) = 1.48 in Nfib-KO;
-1.93 in Nr3c1-KO). The Pearson correlation coefficient
Table 3 Comparison of expression change for some TFs of
interest in Nfib- and Nr3c1-knockout lungs
Nfib-KO Nr3c1-KO
Gene FC p-value FC p-value
Nfib *2.75 < 10−5 2.17 0.001
Nr3c1 1.23 0.172 *3.14 <0.001
Nfia 2.27 0.001 0.61 0.006
Snai2 1.72 < 10−5 1.54 0.003
Meis2 1.57 0.023 2.03 0.012
Nr2f1 1.83 0.001 1.66 0.003
For each knockout, the table shows the expression fold change and the
associated uncorrected p-value (see Methods). The expression changes for Nfib
and Nr3c1 transcripts in their respective KO (marked by an asterisk) occurs in the
context of the transcripts lacking an essential exon and thus no functional
protein is expressed.
between the log2(FC) in the two knockouts of these genes
is 0.907. This strongly suggests that the common phe-
notype in the two knockouts are due to some or all
of the genes in the overlap set. The list of genes acti-
vated/repressed in both datasets is available in Additional
file 2.





Observed overlap 52 22
Expected overlap 4.0 2.5
Overlap fold enrichment 13.1 9.0
Overlap enrichment p-value < 10−46 < 10−15
The table shows the sizes of the sets of activated and repressed genes for NFIB
and GR, the size of the overlaps of the gene sets, the expected overlap size, fold
enrichment of the overlap and the p-value of the overlap enrichment. Note that
to compute the enrichment p-value, we must consider only the genes for which
we have expression data for both knockouts (9990 genes), so the numbers of
activated/repressed genes in this table are different than the numbers reported
for the individual knockouts.
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Figure 6 Expression change of genes activated/repressed in
both Nfib-KO and Nr3c1-KOmice is highly correlated. Each point
represents a gene activated/repressed in both knockouts. Expression
change is expressed as log2(KO/WT), and only genes with a 2-fold
change and a q-value less than 0.05 in both knockouts are shown.
Promoters of genes that are activated by both NFIB and GR
are enriched in NFIB and GRmotifs
To further test our hypothesis that Nfib and Nr3c1 co-
regulate an overlapping set of genes, we looked for
motif enrichment in the sets of commonly activated or
repressed genes identified above. Figure 7 shows the dis-
tribution of the MAS score for 739 motifs in the Jolma
Figure 7Motif Association Score distribution for Nfib and Nr3c1
targets. The histogram shows the distribution of the MAS for the 739
motifs in the compendium (our ChIP-seq motif inferred with MEME
(Nfib_MEME) plus 738 mouse and human TF motifs determined by
SELEX [14]).
et al. [14] compendium, and the relative position of the
GR (NR3C1) and NFIB motifs. We note that the MAS
score of the two motifs are highly significant and among
the largest positive ones, ranking at the 8th and 12th
positions, respectively (Table 5). The complete results are
available in Additional file 3.
Among the motifs with a larger (but similar) positive
MAS, we find the androgen receptor (which is almost
identical to GR), the EBFI motif, motifs for two mem-
bers of the T-box family of transcription factors and the
ZNF410 motif. However, none of the mouse genes corre-
sponding to these motifs shows a significant (p- value ≤
0.05) expression change in both theNr3c1 andNfib knock-
outs. We also note the large negative MAS of Foxi1 and
some estrogen-related receptors (Esrra, Esrrb). Estrogen
controls many cellular processes such as growth and dif-
ferentiation. While Esrrb is over-expressed in the Nr3c1-
KO, we identified no such dysregulation in the Nfib-KO.
We have no expression data for Foxi1 in Nfib-KO, and
this gene is not dysregulated in the Nr3c1-KO. However,
some other genes of the same Fox family are dysregu-
lated in both knockouts, such as Foxp2 (over-expressed in
both) and Foxn3 (under-expressed inNr3c1-KO and over-
expressed in Nfib-KO). Interestingly, it has been shown
that loss of Foxp2 leads to defective postnatal lung alveo-
larization in mouse [28].
Similarly to what we did in a previous section, we
repeated the MAS analysis using human and rat orthol-
ogous sequences. For human, NFIX ranked third (pact <
10−4), and NFIB ranked nineteenth (pact < 10−2). For
rat, NFIX ranked sixth (pact < 10−3), and NFIB ranked
eighth (pact < 10−2). This suggests that NFIB activates
some NR3C1-activated genes through binding at their
promoter sequences. However, NR3C1 did not show a
significant enrichment for human, and it ranked only
51st in rat (pact = 0.044). These data suggest that in
some instances mechanisms other than direct binding
of promoter sequences by NR3C1 may mediate co-
regulation by NR3C1 and NFIB. Consistent with this
finding, previous studies have indicated that some func-
tions of NR3C1 are mediated by mechanisms other
than direct NR3C1 binding to DNA. For example, mice
defective in DNA-binding by NR3C1 are viable while
those deleted for NR3C1 die at birth [29]. Thus it will
be important to determine the fraction of co-regulated
genes whose expression is regulated by direct bind-
ing of NR3C1 versus other indirect mechanisms of
regulation.
Regulatory sub-network involving Nfib and Nr3c1
Based on the data presented above, we propose a pos-
sible regulatory sub-network involving Nfib, Nr3c1, Nfia
and their 52 common activated target genes (Figure 8).
Each of the links represents activation (pointed arrow) or
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Table 5 Association of TFmotifs with Nfib and Nr3c1 common targets
Rank Motif Gene FCNfib FCNr3c1 pact prep MAS
1 AR_full Ar - - 0.0013 0.97 2.86
2 TBR1_full Tbr1 NA - 0.0016 0.19 2.79
3 EBF1_full Ebf1 - - 0.0018 0.89 2.75
4 TBX2_full_2 Tbx2 - - 0.0020 0.37 2.71
5 ZNF410_DBD Zfp410 1.24 - 0.0025 0.90 2.60
6 NR3C2_DBD Nr3c2 - - 0.0036 0.82 2.44
7 Ar_DBD Ar - - 0.0038 0.93 2.42
8 NR3C1_DBD Nr3c1 - *3.14 0.0042 0.84 2.38
9 TBX1_DBD Tbx1 - - 0.0048 0.01 2.32
10 AR_DBD Ar - - 0.0054 0.75 2.26
11 EOMES_DBD Eomes NA - 0.0057 0.14 2.24
12 NFIB_full Nfib *2.75 2.17 0.0060 0.13 2.22
... ... ... ... ... ... ... ...
732 ESRRB_DBD Esrrb NA 1.31 0.10 0.0071 -2.15
733 MEF2A_DBD Mef2a 0.72 - 0.91 0.0060 -2.22
734 POU3F1_DBD_2 Pouf3f1 NA NA 0.97 0.0050 -2.30
735 ESRRG_full_3 Esrrg - - 0.14 0.0038 -2.42
736 OTX1_DBD Otx1 NA NA 0.78 0.0036 -2.44
737 Esrra_DBD_2 Esrra NA NA 0.03 0.0008 -3.10
738 ESRRA_DBD Esrra NA NA 0.13 0.0005 -3.26
739 FOXI1_full_2 Foxi1 NA - 0.62 < 10−4 -4.01
The table shows the rank of the MAS score (rank), the motif name (motif), the associated gene name (gene), the expression fold-change (FC) of the gene in each KO,
the (unadjusted) motif enrichment p-value in the activated set of genes (pact ), the (unadjusted) motif enrichment p-value in the repressed set of genes (prep) and the
motif association score (MAS). “NA” indicates that no expression data is available for the TF gene and “-” indicates that expression change is not significant
(p-value> 0.05). Motif names all in uppercase are for human TFs, others are for mouse TFs. *Note that these FC apply to the disrupted transcripts, and that no
functional protein is produced for Nfib and Nr3c1.
Figure 8 Possible regulatory sub-network involving Nfib, Nfia
and Nr3c1. A flat head on an edge indicates a repressive effect. The
connector labeled 5 indicates cooperative activation by both Nfib and
Nr3c1. Evidence for each numbered edge is given in the main text.
The 52 activated genes are 2-fold over-expressed in the wildtypes
compared to Nfib-KO and Nfib-KO, with a q-value≤ 0.05.
repression (flat arrow) of transcription by a transcription
factor. Each of the links in the figure is numbered, and we
describe the experimental support for each link in what
follows.
Firstly, as shown in Table 2 and discussed above, Nfib
and Nfia transcripts are both repressed by NFIB, which is
indicated by links 1 and 2 in Figure 8. For simplicity, and
because both NFIA and NFIB are transcription factors
and thus can act directly to affect transcription, we depict
these as direct interactions, but they may well be indirect.
The repression of Nfia by Nfib is further supported by
the observation that Nfia is significantly under-expressed
(p < 10−5) while Nfib is significantly over-expressed
(p = 0.001) in the Nr3c1-KO (Table 3).
Secondly, both Nr3c1 and Nfib transcripts are signi-
ficantly repressed by GR (p<0.001 and p=0.001, respec-
tively, Table 3), which we indicate by links 3 and 4 in
Figure 8. We once again depict these as direct interactions
for simplicity.
Thirdly, we propose that the set of 52 genes under-
expressed in both knockouts (hereafter G52) are activated
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cooperatively byNfib andNr3c1.While theremay be some
indirect regulation at play, our motif analysis revealed
a significant enrichment for both NFIB and GR motifs
in this set, which suggests that some of these genes are
direct targets of these factors. Moreover, the two alterna-
tive trivial topologies that could connect Nfib and Nr3c1
to G52 are not supported by the data. Indeed, the topology
Nr3c1 → Nfib → G52
is precluded by the data supporting edge 3, and the topol-
ogy
Nfib → Nr3c1 → G52
would involve under-expression of Nr3c1 in the Nfib-KO,
which is not observed. We indicate the direct cooperation
hypothesis by link 5 in Figure 8.
Finally, since the DNA binding affinities of NFIA and
NFIB are highly similar (see motif logos in Figure 5), we
infer that NFIAmay bindmany of the same regulatory ele-
ments as NFIB. We therefore hypothesize that Nfia may
regulate the genes in G52, which we indicate by link 6
Figure 8. However, it is not clear from the available data
whether Nfia acts as a repressor or an activator of these
genes.
GO analysis of putative common targets of Nfib and Nr3c1
To identify which biological processes could be acti-
vated by Nfib and Nr3c1, we tested for gene-annotation
enrichment using GOrilla [30] and a ranked list approach
(see Methods). We found significant enrichment for sev-
eral general terms including “cell adhesion” (q-value =
0.03), “transport” (q-value = 0.0006) and “immune system
process” (q-value = 0.004), but this required the inclusion
of genes that are not in the set of 52 putative common
targets (i.e. genes that appear under-expressed in both
knockouts, but that do not meet our strict fold-change
and q-value thresholds, see Methods). This suggests that
bothNfib andNr3c1may regulate these processes in some
manner during lung development. On the other hand,
we found significant enrichment for three specific terms
where Nfib and Nr3c1 are more likely to play a direct
role since the associated genes are among the 52 com-
mon targets we have identified: First, “cellular defense
response” (q-value = 0.03), with the Tnfrsf4 (tumor necro-
sis factor receptor superfamily, member 4) and Ncf1
(neutrophil cytosolic factor 1) genes; Second, “regula-
tion of vascular endothelial growth factor signaling path-
way” (q-value = 0.02), with the Myoc1c (myosin ic) and
Xdh (xanthine dehydrogenase) genes; Third, “regulation
of fibroblast proliferation” (q-value = 0.04), with Sphk1
(sphingosine kinase 1), Aqp1 (aquaporin 1) and Cdkn1a
(cyclin-dependent kinase inhibitor 1a) genes. We are cur-
rently examining these genes inmore detail to assess NFIB
and GR binding to putative regulatory regions.
Discussion
Lung maturation is a complex process dependent on
cooperation between the mesenchyme, epithelium and
endothelial cells to promote vascularization, epithelial dif-
ferentiation, mesenchyme thinning and lung morphogen-
esis [1,2]. Previous studies using transcriptional profiling
have identified large numbers of genes whose expression
levels change substantially during each of the character-
istic stages of mouse lung development: 1) embryonic, 2)
pseudoglandular, 3) canalicular, 4) saccular and 5) alveolar
[31-33]. For example Mariani et al. demonstrated groups
of extracellular matrix genes that exhibit stage-specific
expression patterns in mouse lung [32,33]. However the
vast majority of these changes in gene expression repre-
sent stage-specific differentiation markers of epithelial or
mesenchymal cells which define the cellular phenotype
at each stage, but give little information on the regula-
tory mechanisms that control the differentiation process.
Conversely, genetic studies have been instrumental in the
discovery of gene regulatory pathways essential for early,
and to a lesser extent, later stages of lung development. For
example, reciprocal epithelial-mesenchymal inductions
have been shown to be essential for both early and late
stages of lung development [7,34,35]. In addition, while a
number of signaling pathways including the FGF [36,37],
Shh [38,39], BMP [40,41], Wnt [42] and TGF [43,44] path-
ways are known to signal within and between the epithe-
lium and mesenchyme, the transcriptional networks that
respond to and/or generate these pathways and mediate
the maturation program remain largely unknown [2,45].
Both the NFIB and GR transcription factors have
been shown previously to regulate the transition from
the canalicular to the saccular stage in mouse lung
[5,10,46,47]. Indeed mutations in either gene result in
a very similar phenotype characterized by an excess of
mesenchymal and epithelial cells at E18, severe reduction
or failure of saccule formation, severe delay in type I
and type II cell differentiation and resultant perinatal
lethality with largely non-inflated lungs. More recently
it was determined using conditional KO alleles that Nfib
and Nr3c1 expression in the lung mesenchyme, not lung
epithelium, is essential for normal lung maturation [6,11].
The similarity in phenotype seen with loss of either Nfib
or Nr3c1 initially suggested that these two transcription
factors might be cooperating in a conserved pathway of
lung maturation. Our determination of a significant over-
lap between the genes whose expression changes with the
loss of either Nfib or Nr3c1 (Table 4 and Figure 6) in lung
mesenchyme is consistent with this hypothesis. In addi-
tion, the motif analysis showed significant enrichment of
NFI and GR binding motifs in genes whose expression
decreased in bothNfib-KO andNr3c1-KO lungs (Figure 7)
suggesting cooperative activation of these genes by
these factors.
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Conclusions
Our computational analysis combining expression, bind-
ing and motif data provide the first evidence for Nfib
andNr3c1 co-regulating genes related to lung maturation.
Although these data are consistent with the model of Nfib
and Nr3c1 function shown in Figure 8, other models are
possible. For example, it may be that the overlap in dif-
ferentially expressed genes in the two mutants (Table 4)
is a reflection of the overall phenotype (lung immatu-
rity) rather than being causally dependent on direct co-
regulation byNfib andNr3c1. To distinguish between such
alternate hypotheses it will be necessary to simultane-
ous assess GR and NFIB binding to mouse lung target
genes and assess the frequency of co-occupancy at poten-
tial target genes. While GR ChIP-seq data is available for
human lung cancer cells [48], rat pheochromocytoma cells
[49] and mouse adipocytes [50], because GR binding to
DNA is highly dependent on chromatin context and thus
shows high cell-type specificity [51] these data sets are of
marginal use at best for determining GR targets in normal
lung mesenchyme. In addition, while the ChIP-seq data
set used here for NFIB was determined at E16.5, it will be
necessary to assess both NFIB and GR binding at multi-
ple stages of lung development to determine the temporal
sequence during which NFIB and GR bind to target sites
to regulate gene expression. However, even in the absence
of such data our determination that both NFIB and GR
binding motifs are among those most highly associated
with genes whose expression is decreased by loss of either




E16.5 wild type lungs were minced on ice in PBS, incu-
bated in 1% formaldehyde at room temperature for 10
min., quenched with 0.125M glycine for 5 min. and pre-
pared for chromatin isolation as described previously
[6]. Chromatin was sheared to ∼200–500 bp using a
Branson Sonifier 250 sonicator and subjected to ChIP
using a ChIP assay kit (Upstate Biotechnology) and NFIB
antibody (Geneka Biotechnology). Immunoprecipitated
chromatin was isolated, the crosslinks reversed, and the
isolated DNA was used to prepare a sequencing library
and sequenced at the Cornell University DNA Sequenc-
ing and Genotyping Laboratory, resulting in 8,717,818
unpaired reads of 42bp.
Reads were aligned to the mouse genome (mm9) using
Bowtie2 software [52] with default parameters. 2,311,332
reads (26.51%) aligned at a unique location and 971,349
(11.14%) aligned to more than one location. Reads with
a mapping quality score (MAPQ) below 30 were dis-
carded. The remaining reads were then used to call peaks
with the MACS1.4 software [53], using default parame-
ter values except for the following: -g 1.87e9 (effective
genome size) -m 5,30 (MFOLD parameter). The list of
peak summits output by MACS is available in Additional
file 4. De novo motif discovery was performed on the
100bp sequences centered around each peak summit with
repeats masked (mm9, downloaded from UCSC), using
the MEME software [12]. DNA sequences were shuffled
using the uShuffle software [54] with parameter k=3 to
preserve trinucleotide frequencies.
Microarray analysis
For Nfib-KO, we used the mRNA expression profiling
datasets published in [6]. In this KO strain only exon
2 is deleted from the Nfib gene leaving the remaining
exons present for detection in the microarray analysis.
These datasets have been produced using Affymetrix
arrays and are available at the NCBI Gene Expression
Omnibus (GEO) data repository under Accession number
GSE24465. The probe intensity signals were normalized
using the GC-RMA algorithm.
For Nr3c1-KO, we used the datasets published in [27].
These datasets have been produced using Codelink BioAr-
rays and are available at the ArrayExpress data reposi-
tory under Accession number E-MEXP-861. The signal
of the probes with “Good quality” flag was extracted,
log2-transformed and quantile normalized using R.
For both datasets, differential expression and p-values
were calculated using the linear model implemented
in the R Limma package (Smyth, 2004), and q-values
were obtained from the p-values using the Benjamini-
Hochberg method (they are referred to as adjusted p-
values in the Limma output). For downstream analysis, we
considered only the probe set with the most significant
result for each gene. The complete results with all probes
are available in Additional files 5 and 6. Note that differen-
tial expression is expressed as log2(KO/WT) in Additional
files 5 and 6, but are simply expressed as ratio (KO/WT)
in the main text.
In this paper we will refer to a gene as activated by TF X
if its expression decreases at least 2-fold in the knockout
of X, with a q-value ≤ 0.05. Similarly, we will say that a
gene is repressed by X if its expression increases at least
2-fold in the KO of X, with a q-value ≤ 0.05. These two
definitions define three sets of genes:
• X-activated genes: KO/WT ≤ 0.5 and q-value ≤ 0.05,
• X-repressed genes: KO/WT ≥ 2 and q-value ≤ 0.05,
and
• X-non-target genes: All other genes for which we
have expression data.
Of course we are using the terms “activated” and
“repressed” somewhat loosely here, since these sets of
Lajoie et al. BMC Genomics 2014, 15:231 Page 11 of 13
http://www.biomedcentral.com/1471-2164/15/231
genes will include both direct and indirect regulatory
targets of TF X.
We use q-values in the above definition to take multiple
testing into account. However, when we refer to a particu-
lar gene that has been selected using another criteria (e.g.
a motif analysis), we report unadjusted p-values of differ-
ential expression, and we say that this gene is dysregulated
if its p-value ≤ 0.05, without enforcing any fold change
threshold.
Motif enrichment in promoters of target genes
To determine how a given motif M is associated with
the regulatory targets of TF X, we measure the enrich-
ment of M in the proximal promoters of genes activated
or repressed by X, relative to the promoters of non-target
genes. (Note that the motif M can be any motif, not just
that of the TF X).
First, we use motif M to scan the proximal promoter
of each gene, defined as the region within 1000 bp of
its TSS, and save the best score for each promoter. We
then determine pact , the p-value of a Wilcoxon rank-sum
test [55] with the null hypothesis that the promoter motif
scores are no better in the activated genes compared to the
non-target genes. Similarly, prep is the p-value when we
test the scores of the repressed genes compared with the
non-target genes. For analysis and plotting purposes, we
combine these two p-values into a single motif association
score (MAS), whose magnitude is log10(min(pact , prep)),
and whose sign is positive if the motif M is more signif-
icantly enriched in the activated genes, pact ≤ prep, and
negative otherwise.
In the current work, we first compute the MAS for Nfib
targets using each of the 738 motifs in the compendium
of SELEX-based motifs published by Jolma et al. [14]. In
a subsequent analysis, we compute the MAS for the com-
mon targets ofNfib andNr3c1. In this case, the “activated”
set of genes is simply the intersection of theNfib-activated
and Nr3c1-activated, likewise for the “repressed” set of
genes. The set of “non-targets” is the intersection of the
Nfib-non-targets and theNr3c1-non-targets.We note that
since pact and prep are not adjusted formultiple tests, MAS
should be viewed as a score rather than as a true statistical
confidence measure.
We extracted TSS coordinates from the UCSC browser
KnownGene table. When a gene has multiple TSSs, we
used the one corresponding to the shortest transcript.
Intersection between Nfib and Nr3c1 targets
The size of the overlap z between two independent sets
A and B, each sampled without replacement from a set
C, follows a hypergeometric distribution with parameters
m = |A|, n = |C| − |A| and k = |B|, where |X| denotes the
number of elements in setX. IfC is the set of all genes, and
A and B are two sets of target genes, the probability that
their intersection contains z or more genes (under the null
model) can be obtained in the R programming language
with a call to the hypergeometric distribution function
phyper(z-1,m,n,k,lower.tail=FALSE). The
expected size of the overlap is equal tomk/(n + m).
GO-term analysis
All genes were ranked according to their likeliness of being
activated by both Nfib and Nr3c1, with the most likely at
the top of the list. To achieve this, we used the maximum
of the fold-change (KO/WT) observed in either the Nfib-
KO or the Nr3c1-KO as a sorting key. This ranked list of
genes was used as input to GOrilla with default param-
eters [30], and a q-value threshold of 0.05 was used to
define significant results.
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